Well, if that's the case, Lopez, that "Cavatak is worth big money to other companies", those other companies would surely be making a counter offer soon. It would not make sense for them to sit on their laurels in the hope that the shareholders will vote against the current offer. My attitude is that if a counter offer is not forthcoming, then Merck's offer is what it is... fair and reasonable. My point confirmed: why vote against the offer???
- Forums
- ASX - By Stock
- VLA
- 63 Million Shares traded since announcement
63 Million Shares traded since announcement, page-33
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online